YTHDF1 and colorectal carcinoma: Furthermore, random forest machine learning analysis of a public CRC patient dataset (cohort V, N = 83) with chemotherapy responders and nonresponders revealed that elevated YTHDF1 expression was associated with chemotherapy nonresponders (AUC = 75.9%, 95% CI: 57.72%–94.08%) (Fig. 8e).